B-intervention	0	15	Chemoprevention
O	16	22	Uptake
O	23	26	for
O	27	33	Breast
O	34	40	Cancer
O	41	45	Risk
O	46	55	Reduction
O	56	62	Varies
O	63	65	by
O	66	70	Risk
O	71	77	Factor
O	77	78	.

O	79	82	The
O	83	91	efficacy
O	92	94	of
O	95	110	chemoprevention
O	111	114	for
O	115	121	breast
O	122	128	cancer
O	129	133	risk
O	134	143	reduction
O	144	147	has
O	148	152	been
O	153	165	demonstrated
O	166	168	in
O	169	179	randomized
O	180	190	controlled
O	191	197	trials
O	197	198	;
O	199	206	however
O	206	207	,
O	208	211	use
O	212	219	remains
O	220	223	low
O	223	224	.

O	225	227	We
O	228	234	sought
O	235	237	to
O	238	247	determine
O	248	255	whether
O	256	262	uptake
O	263	271	differed
O	272	274	by
O	275	279	risk
O	280	287	factors
O	287	288	,
O	289	292	and
O	293	295	to
O	296	304	identify
O	305	312	reasons
O	313	316	for
O	317	324	refusal
O	325	328	and
O	329	340	termination
O	340	341	.

B-eligibility	342	347	Women
I-eligibility	348	352	seen
I-eligibility	353	355	in
I-eligibility	356	357	a
I-eligibility	358	362	high
I-eligibility	362	363	-
I-eligibility	363	367	risk
I-eligibility	368	374	clinic
O	375	379	from
O	380	387	October
O	388	392	2014
O	393	395	to
O	396	400	June
O	401	405	2017
O	406	416	considered
O	417	425	eligible
O	426	429	for
O	430	445	chemoprevention
O	446	447	(
O	447	454	history
O	455	457	of
O	458	465	lobular
O	466	475	carcinoma
O	476	478	in
O	479	483	situ
O	483	484	,
O	485	491	atypia
O	491	492	,
O	493	499	family
O	500	507	history
O	508	510	of
O	511	517	breast
O	517	518	/
O	518	525	ovarian
O	526	532	cancer
O	532	533	,
O	534	541	genetic
O	542	550	mutation
O	550	551	,
O	552	554	or
O	555	562	history
O	563	565	of
O	566	571	chest
O	572	576	wall
O	577	586	radiation
O	586	587	)
O	588	592	were
O	593	608	retrospectively
O	609	619	identified
O	619	620	.

O	621	627	Breast
O	628	634	cancer
O	635	639	risk
O	640	647	factors
O	648	652	were
O	653	661	compared
O	662	667	among
O	668	673	those
O	674	678	with
O	679	682	and
O	683	690	without
O	691	706	chemoprevention
O	707	710	use
O	710	711	,
O	712	715	and
O	716	726	compliance
O	727	730	was
O	731	736	noted
O	736	737	.

O	738	745	Overall
O	745	746	,
B-total-participants	747	751	1506
O	752	757	women
O	758	762	were
O	763	773	identified
O	773	774	,
O	775	777	24
O	777	778	%
O	779	783	with
O	784	789	prior
O	789	790	/
O	790	797	current
O	798	813	chemoprevention
O	814	817	use
O	817	818	.

O	819	824	Women
O	825	826	≥
O	827	829	50
O	830	835	years
O	836	838	of
O	839	842	age
O	843	847	were
O	848	852	more
B-outcome	853	859	likely
I-outcome	860	862	to
I-outcome	863	866	use
I-outcome	867	882	chemoprevention
O	883	887	than
O	888	893	women
O	894	895	<
O	896	898	50
O	899	904	years
O	905	907	of
O	908	911	age
O	912	913	(
O	913	915	28
O	915	916	%
O	917	919	vs
O	919	920	.
O	921	923	11
O	923	924	%
O	924	925	,
O	926	927	p
O	928	929	<
O	930	931	0
O	931	932	.
O	932	935	001
O	935	936	)
O	936	937	.

B-outcome	938	953	Chemoprevention
I-outcome	954	957	use
I-outcome	958	960	by
I-outcome	961	965	risk
I-outcome	966	972	factor
O	973	979	ranged
O	980	984	from
O	985	986	7
O	987	989	to
O	990	992	40
O	992	993	%
O	993	994	.

O	995	1001	Having
O	1002	1010	multiple
O	1011	1015	risk
O	1016	1023	factors
O	1024	1027	did
O	1028	1031	not
O	1032	1040	increase
O	1041	1044	use
O	1044	1045	.

O	1046	1057	Significant
O	1058	1067	variation
O	1068	1070	by
O	1071	1075	risk
O	1076	1082	factor
O	1083	1086	was
O	1087	1094	present
O	1095	1100	among
O	1101	1106	women
O	1107	1108	≥
O	1109	1111	50
O	1112	1117	years
O	1118	1120	of
O	1121	1124	age
O	1125	1126	(
O	1126	1127	p
O	1128	1129	<
O	1130	1131	0
O	1131	1132	.
O	1132	1135	001
O	1135	1136	)
O	1136	1137	,
O	1138	1141	but
O	1142	1145	not
O	1146	1151	among
O	1152	1157	women
O	1158	1159	<
O	1160	1162	50
O	1163	1168	years
O	1169	1171	of
O	1172	1175	age
O	1176	1177	(
O	1177	1178	p
O	1179	1180	=
O	1181	1182	0
O	1182	1183	.
O	1183	1184	1
O	1184	1185	)
O	1185	1186	.

O	1187	1192	Among
O	1193	1198	women
O	1199	1203	with
O	1204	1205	a
O	1206	1216	documented
O	1217	1227	discussion
O	1228	1237	regarding
O	1238	1253	chemoprevention
O	1254	1255	(
O	1255	1258	575
O	1258	1259	/
O	1259	1263	1141
O	1263	1264	)
O	1264	1265	,
B-outcome	1266	1270	fear
I-outcome	1271	1273	of
I-outcome	1274	1281	adverse
I-outcome	1282	1289	effects
O	1290	1293	was
O	1294	1297	the
O	1298	1302	most
O	1303	1309	common
O	1310	1317	refusal
O	1318	1324	reason
O	1325	1326	(
B-iv-bin-abs	1326	1328	57
O	1328	1329	/
B-intervention-participants	1329	1332	156
O	1332	1333	;
B-iv-bin-percent	1334	1336	36
I-iv-bin-percent	1336	1337	%
O	1337	1338	)
O	1338	1339	.

O	1340	1343	The
O	1344	1352	majority
O	1353	1355	of
O	1356	1361	women
O	1362	1363	(
O	1363	1365	61
O	1365	1366	%
O	1366	1367	)
O	1368	1371	who
O	1372	1381	initiated
O	1382	1397	chemoprevention
O	1398	1407	completed
O	1408	1409	5
O	1410	1415	years
O	1415	1416	.

O	1417	1432	Chemoprevention
O	1433	1436	use
O	1437	1442	among
O	1443	1448	women
O	1449	1451	at
O	1452	1461	increased
B-outcome	1462	1466	risk
I-outcome	1467	1470	for
I-outcome	1471	1477	breast
I-outcome	1478	1484	cancer
O	1485	1492	remains
O	1493	1496	low
O	1496	1497	,
O	1498	1502	with
O	1503	1507	more
O	1508	1516	frequent
O	1517	1520	use
O	1521	1526	among
O	1527	1532	women
O	1533	1534	≥
O	1535	1537	50
O	1538	1543	years
O	1544	1546	of
O	1547	1550	age
O	1550	1551	.

O	1552	1557	These
O	1558	1562	data
O	1563	1572	highlight
O	1573	1576	the
O	1577	1581	need
O	1582	1585	for
O	1586	1593	ongoing
O	1594	1605	educational
O	1606	1613	efforts
O	1614	1617	and
O	1618	1628	counseling
O	1628	1629	,
O	1630	1632	as
O	1633	1636	the
O	1637	1645	majority
O	1646	1649	who
O	1650	1655	begin
O	1656	1663	therapy
O	1664	1672	complete
O	1673	1674	5
O	1675	1680	years
O	1681	1683	of
O	1684	1687	use
O	1687	1688	.

O	1689	1694	Given
O	1695	1698	the
O	1699	1703	fear
O	1704	1706	of
O	1707	1714	adverse
O	1715	1722	effects
O	1723	1725	as
O	1726	1730	well
O	1731	1733	as
O	1734	1737	low
O	1738	1744	uptake
O	1744	1745	,
O	1746	1758	particularly
O	1759	1764	among
O	1765	1770	women
O	1771	1772	<
O	1773	1775	50
O	1776	1781	years
O	1782	1784	of
O	1785	1788	age
O	1788	1789	,
O	1790	1801	alternative
O	1802	1806	risk
O	1806	1807	-
O	1807	1815	reducing
O	1816	1826	strategies
O	1827	1830	are
O	1831	1837	needed
O	1837	1838	.
